Kelyniam Global, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLYG research report →
About the company
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers.
- CEO
- Ross Bjella
- IPO
- 2008
- Employees
- 9
- HQ
- Collinsville, CT, US
Price Chart
- Market Cap
- $1.64M
- P/E
- -185.71
- P/S
- 0.46
- P/B
- 8.55
- EV/EBITDA
- 5.30
- Div Yield
- 0.00%
- Gross Margin
- 78.74%
- Op Margin
- 8.91%
- Net Margin
- -0.91%
- ROE
- -4.32%
- ROIC
- 9.67%
- Revenue
- $3.05M · -8.27%
- Net Income
- $-138,555 · 84.94%
- EPS
- $-0.00 · 84.86%
- Op Income
- $-107,913
- FCF YoY
- -299.81%
- 52W High
- $0.30
- 52W Low
- $0.05
- 50D MA
- $0.14
- 200D MA
- $0.13
- Beta
- -0.06
- Avg Volume
- 21.42K
Get TickerSpark's AI analysis on KLYG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 08 | Ketner James | other | 35,000 |
| Jun 25, 08 | Ketner James | other | 500,000 |
| Apr 7, 08 | Ketner James | buy | 4,800 |
| Apr 7, 08 | Ketner James | buy | 4,800 |
| Apr 3, 08 | Ketner James | other | 200,000 |
| Apr 3, 08 | Ketner James | buy | 5,000 |
Our KLYG coverage
Recent articles, reports, and earnings notes.
No research on KLYG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KLYG report →Similar companies
Peers in the same neighborhood.